United States · Platforms & data · Seeking Alpha

NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M

Published by Seeking Alpha · United States 1 d ago

NeuroPace expects ~15% RNS growth in 2027 as it revises 2026 revenue guidance to $91M-$92M — Seeking Alpha

Detailed summary

NeuroPace cuts 2026 revenue guidance to $91 million-$92 million after Q3 revenue falls 1.1% to $23.1 million amid large-account disruptions.

Read the full article on Seeking Alpha Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (seekingalpha.com)

Also worth reading

Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average Following Weak Earnings

Venture Global senior VP Fory Musser sells $6.58M in stock

The Motley Fool

Why Liftoff Mobile Stock Soared 30% on Friday

FAA lifts rare nationwide ground stop on flights; air travel may take days to recover

Lutnick faces questions over Nvidia spy scandal. His sons' firm has deep ties to the chipmaker

Nvidia Loses Its Founder, AMD and Broadcom Take the Crown: This Week on Wall Street